期刊文献+

熊果酸诱导结肠癌HT-29细胞凋亡与凋亡相关基因的关系 被引量:8

Relationship between apoptosis in HT-29 cell induced by ursolic acid and expression of caspase-9,bcl-2 and bax
下载PDF
导出
摘要 目的:体外实验探讨熊果酸诱导结肠癌HT-29细胞凋亡的可能性,揭示该凋亡发生与其相关基因之间的关系。方法:采用四甲基偶氮唑蓝比色、TUNEL法、流式细胞术检测熊果酸对结肠癌HT-29细胞的增殖抑制与杀伤作用;应用免疫组织化学SP法检测凋亡相关基因caspase-9、bcl-2、bax的表达。结果:熊果酸在体外对HT-29细胞有中度增殖抑制效应,在熊果酸作用下,HT-29细胞出现显著的细胞凋亡征象,TUNEL法显示细胞固缩,核染色质聚集或断裂,形成凋亡小体。流式细胞术检测在G 1期之前出现sub-G1峰,凋亡率最高为11.63%,熊果酸的作用具有浓度和时间依赖性。在HT-29细胞凋亡过程中,凋亡相关基因caspase-9、bax的表达增强,bcl-2的表达减弱。结论:熊果酸在体外对结肠癌HT-29细胞有诱导凋亡作用,而caspase-9和bax的表达增强,bcl-2的表达减弱可能是其作用机制之一。 Objective To study the antitumor effect of ursolic acid and its mechanism. Methods The human colorectal carcinoma HT-29 cells were treated with ursolic acid. The proliferation inhibitory was examined by MTT method. Morphological study, TUNEL method and flow cytometry were used to detect apoptosis. Immunohistochemical method was used to detect the expression of apoptosis related gene caspase-9, bcl-2 and bax. Results Ursolic acid inhibited the proliferation of HT-29 cell. HT-29 cell treated with ursolic acid was induced to apoptosis. The morphology of HT-29 changed as nuclear chromosomal condensation and segmentation. Sub-G1 peak was found with flow cytometry. The expression of caspase-9 and bax gene was enhanced. The expression of bcl-2 gene was weak. Conclusion Apoptosis of HT-29 cell is the key mechanism to ursolic acid's killing action in the treatment of cancer.
作者 沈岚 谭洁
出处 《实用诊断与治疗杂志》 2006年第11期784-786,F0004,共4页 Journal of Practical Diagnosis and Therapy
关键词 结肠癌 熊果酸 HT-29细胞 细胞凋亡 CASPASE-9 bcl-2 bax Colon carcinoma ursolic acid HT-29 cell cell apoptosis Caspase-9 bcl-2 bax
  • 相关文献

参考文献9

  • 1Ladislav Novotny, Mohammed E Abdel-Hamid, Hoda Hamza,et al. Development of LC-/MS method for determination of ursolic acid: application to the analysis of ursolic acid in Staphylea holocarpa Hemsl[J]. Pharm Biomed Anal,2003,31 (5):961
  • 2Banno N, Akihisa T, Tokuda H, et al. Triterpene acids from the leaves of Perilla frutescens and their anti-inflammatory and antitumor-promoting effects [J]. Biosci Biotechnol Biochem,2004,68(1):85
  • 3Kim D K, Baek J H, Kang C M, et al. Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication[J]. Int J Cancer,2000, 87(5): 629
  • 4Mizushina Y, Iida A, Ohta K, et al. Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase[J]. The Bioehe J,2000,350(3): 757
  • 5Lauthier F, Taillet L, Trouillas P, et al. Ursolic acid triggers calcium-dependent apoptosis in human Daudi cells [J].Anticancer Drugs, 2000, 11(9) : 737
  • 6Choi Y H, Baek J H, Yoo M A, et al. Induction of apoptosis by ursolic acid through activation of caspases and down regulation of c- IAPs in human prostate epithelial cells[J]. Int J Oncol, 2000,17(3):565
  • 7Novotny L, Vacalkova A, Biggs D. Ursolic acid: antitumorigenic and chemopreventive activity [J]. Minireview Neoplasma, 2001, 48(4):241
  • 8Li Y, Bhuiyan M, Mohammad R M, et al. Induction of apoptosis in breast cancer cells by TPA[J]. Oncogene, 1998, 17(22):2915.
  • 9张立华,银平章,鲍玉洲.EGF和EGFR在结肠癌研究中的新进展[J].实用诊断与治疗杂志,2004,18(3):203-205. 被引量:5

二级参考文献18

  • 1Huang S M, Bock J M, Harari P M. Epidermal growth factor receptor blockade with C225 modulates proliferation, apotosis,and radiosensitivity in squamous cell carcinomas of the head and neck[J]. Cancer Res,1999, 59(8):1935
  • 2Milas L, Mason K, Hunter N, et al. In vivo enchancement of tumor radioresponse by C225 anti-epidermal growth factor receptor antibody[J]. Clin Cancer Res, 2000,6 (2) : 701
  • 3Salomon D S, Brandt R, Ciardiello F.et al. Epidermal growth factor-related pcptide and receptors in human malignancies[J].Crit Rev Oncol Hematol, 1995,19(3) :183
  • 4Harai P M, Huang S M. Modulation of molecular targets to enhance radiation[J]. Clin Cancer Rcs, 2000,6(2) :323
  • 5Baselga J, Herbst R, Lorusso P, et al. Constinuous administration of ZD1839, a novel oral epidermal growth factor receptor tyrosinc kinase inhibitir , in patients with five selected tumor types: evidence of activity and good tolerability [A].Proc Am Soc Clin Oncol, 2000,19:177a
  • 6Ferry D, Hammond L, Ranson M, et al. Intermittcnt oral ZD1839, a novel epidermal growth factor receptor tyrosine kinase inhibitor shows early evidence of good tolerability and activity: Final results from a phase I study [J]. Proc Am Soc Clin Oncol, 2000,19: 3a.
  • 7Goldstein N S, Armin M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage Ⅳ colon adcnocarcinoma:implications for a standardized scoring system [J]. Cancer,2001, 92(5) :1331
  • 8De Luca A, Pignata S, Casamassini A, et al. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay [J].Clin Cancer Res, 2000,6(4): 1439
  • 9Herbst R S, Shin D M. Monoclonal antibodies to target epidermal growth factor receptor-positive tumours: a new paradigm for cancer therapy[J ]. Cancer, 2002,94 (5): 1593
  • 10Liu B, Fang M, Schmidt M, et al. Induction of apoptosis and activition of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the Cjun N-terminal kinase activity [J]. Br J Cancer, 2000,82(12):1991

共引文献4

同被引文献97

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部